Home > Boards > US Listed > Miscellaneous >

Diffusion Pharmaceuticals Inc. (DFFN)

DFFN RSS Feed
Add DFFN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/20/2020 12:03:15 PM - Followers: 43 - Board type: Free - Posts Today: 0

Diffusion Pharma files for $50M mixed shelf offering. May 16, 2019 4:50 PM ET. A mixed shelf offering is the ability to offer securities for sale with different size, price and terms which may be determined at the time of  sale. 
http://www.investorwords.com/11701/mixed_shelf.html#ixzz5oac7cWcF   


The biggest obstacle that the company faced was the lack of funds. That has now been resolved. The company will do very good things with the new funds. 

This expected new capital will fund the advancement of lead candidate trans sodium crocetinate (TSC) for the treatment of stroke and cancer.


Diffusion Pharmaceuticals is an absolute homerun once their products comer to market. We are talking a Google-like price tag. They offer an exciting new approach to the treatment of life-threatening diseases where cellular oxygen deprivation (known as “hypoxia”) is a key factor. This lack of oxygen is given different names, usually linked to the location of the oxygen deficiency.

Oxygen deprivation in the brain is a stroke; in the heart it’s a heart attack; in the legs, it’s peripheral arterial disease; systemically it may be respiratory.  Lack of oxygen in a cancerous tumor causes something called treatment resistance.  But wherever it is located and whatever it is called, the lack of oxygen in the human body carries severe consequences which may quickly become deadly.

Diffusion Pharmaceuticals is an absolute homerun once their products comer to market. We are talking a Google like price tag. They offer an exciting new approach to the treatment of those life-threatening diseases where cellular oxygen deprivation (known as “hypoxia”) is a key factor. This lack of oxygen is given different names, usually linked to the location of the oxygen deficiency.

Oxygen deprivation in the brain is a stroke; in the heart it’s a heart attack; in the legs, it’s peripheral arterial disease; systemically it may be respiratory.  Lack of oxygen in a cancerous tumor causes something called treatment resistance.  But wherever it is located and whatever it is called, the lack of oxygen in the human body carries severe consequences which may quickly become deadly.

 

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy.

       The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments.
                               The Company's Diffusion's technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate, TSC, with standard-of-care radiation and chemotherapy regimens, thus effecting a better patient survival outcome without the addition of harmful side effects.
Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types, with an initial focus on primary brain cancer (glioblastoma or GBM), pancreatic cancer, and brain metastases.




ABOUT

Diffusion Pharmaceuticals is a Phase 3 clinical-stage biotech company dedicated to improving the outcome for cancer patients, stroke victims and others afflicted with life-threatening disease where cellular oxygen deprivation (known as ``hypoxia``) is a key factor

 

TECHNOLOGY

Our lead drug, Trans Sodium Crocetinate (“TSC”), targets the oxygen-deprived micro-environment of affected tissue, restoring life-giving oxygen to ischemic cells in stroke making cancer cells more vulnerable to the cancer-killing power of radiation and chemotherapy

 

INDICATIONS

Clinical targets include cancer, where a phase 3 trial in inoperable GBM brain cancer is enrolling patients, and acute ischemic stroke where we have received FDA approval for an innovative phase 2 protocol allowing in-ambulance administration of TSC

 
                                                                      
  • Avg Vol (10-day): 41.0K
    52-Wk Range: 1.83 - 11.00
    Market Cap: 19.9M

                                                                                   
 

 

   .

 

DFFN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#3004   8-K 1 dffn20200316_8k.htm FORM 8-K gmcdonald34 03/20/20 12:03:15 PM
#3003   Buys coming in ah! wedman 03/17/20 04:15:06 PM
#3002   * * $DFFN Video Chart 03-03-2020 * * ClayTrader 03/03/20 03:58:12 PM
#3001   Looks like this is starting to head in gmcdonald34 03/01/20 08:55:27 PM
#3000   https://weekherald.com/2020/02/25/zacks-diffusion-pharmaceuticals-inc-nasdaqdffn clydesur 02/26/20 12:14:12 PM
#2999   Nice news! wedman 02/07/20 08:44:56 AM
#2998   Loaded some here.... 420man 01/14/20 05:40:42 PM
#2997   INSIDER BUYING - PHASE-3 PARTNERSHIP DUE ANY DAY DutchBlood_7 01/13/20 06:07:23 PM
#2996   Yes, because of the offering. More shares = Stefa 01/12/20 03:00:56 AM
#2995   And that was a cut from $10... bcapps66 01/10/20 09:25:51 AM
#2994   Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock decreased by 4.9% to rawsteel 01/08/20 10:25:17 AM
#2993   There are ways to get compliance without a Deagle 01/08/20 02:11:32 AM
#2992   Waiting for another offering... Marvy 01/07/20 03:42:47 PM
#2991   DFFN moving up.50 above the 50ma gonna close dude iligence 01/07/20 02:09:19 PM
#2990   prospectus filed dec 30...…...this could be mm`s working dirtydozen911 01/07/20 11:37:38 AM
#2989   12/11/19 Diffusion Pharmaceuticals Says Received Notice From Nasdaq rawsteel 01/07/20 06:15:14 AM
#2988   * * $DFFN Video Chart 12-31-2019 * * ClayTrader 12/31/19 05:30:40 PM
#2987   December 30, 2019 01:00 PM ET (BZ Newswire) -- clydesur 12/31/19 11:44:25 AM
#2986   I literally added some this am! Glad wedman 12/20/19 04:01:53 PM
#2985   whoa wonder whats goin on kclark55 12/20/19 04:00:57 PM
#2984   Nice move here just now ! wedman 12/20/19 03:56:41 PM
#2983   Any chance that you still follow RBNW? investgood 12/15/19 12:23:51 AM
#2982   Thanks bud bleu22 12/12/19 11:22:43 AM
#2981   Yeah I had a bad feeling somehow and europtiger 12/12/19 11:22:27 AM
#2980   I’m still riding this bull... bleu22 12/12/19 11:21:40 AM
#2979   No rush here. Just watching but their science frankyahoo 12/12/19 11:03:18 AM
#2978   Whats the rush? Their diluting probably to make Dusty18 12/12/19 10:57:26 AM
#2977   Gap fill and 8K on NASDAQ letter probably frankyahoo 12/12/19 10:54:57 AM
#2976   Got out 0,4120 europtiger 12/12/19 09:43:29 AM
#2975   Crazy volume europtiger 12/12/19 09:34:59 AM
#2974   I hope for 0,46 somewhen soon... then let’s see europtiger 12/12/19 09:08:12 AM
#2973   Same to you europtiger 12/12/19 09:07:29 AM
#2972   I got .39’s... GLTU bleu22 12/12/19 09:06:37 AM
#2971   I got 30k yesterday at 0,55 and now europtiger 12/12/19 09:03:04 AM
#2970   Ok, I’m in. Let’s roll... bleu22 12/12/19 08:59:15 AM
#2969   Yeah, I think I’ll grab a starter here bleu22 12/12/19 08:44:32 AM
#2968   Rally donno... but 0,38 imo bottom europtiger 12/12/19 08:43:54 AM
#2967   HMMM... Should I grab some .38’s or sit bleu22 12/12/19 08:42:56 AM
#2966   Oh Ohhh! Looks like dilution just announced. Traders Dusty18 12/12/19 08:16:13 AM
#2965   News: $DFFN Diffusion Pharmaceuticals Inc. Announces $3.5  whytestocks 12/12/19 08:15:18 AM
#2964   That’s the question haha europtiger 12/12/19 08:14:11 AM
#2963   Buying opportunity here. bleu22 12/12/19 08:12:18 AM
#2962   They just had an offer... sucks lol europtiger 12/12/19 08:06:07 AM
#2961   I know all lol sniper01 12/12/19 08:05:16 AM
#2960   How did u know? europtiger 12/12/19 08:03:20 AM
#2959   Now I am lol Offer? europtiger 12/12/19 08:02:30 AM
#2958   I am never disappointed my friend ;) europtiger 12/12/19 07:53:35 AM
#2957   Please don’t be a disappointment today dffn sniper01 12/12/19 07:53:02 AM
#2956   So there was no ah run... there was europtiger 12/12/19 07:01:10 AM
#2955   * * $DFFN Video Chart 12-11-19 * * ClayTrader 12/11/19 05:55:35 PM
PostSubject